Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (20) clinical trials

When psychosis develops, people often suffer symptoms, sometimes for many months. In some people, these symptoms may be an early sign that more serious mental health problems may develop. If you (or a loved one) are living with any of these symptoms, you may be wondering about the development of ...

Phase N/A

Every day can be unpredictable when your loved one has agitation due to Alzheimer’s disease.  The TRIAD™ Research Study is currently evaluating an investigational medication to see if it may reduce symptoms of agitation due to Alzheimer’s disease.  

Phase N/A

A research study is enrolling for those suffering from Mild to Cognitive Impairment due to Alzheimer's Disease.  

Phase

Participate in a clinical trial exploring memory loss at ActivMed Practices and Research, Inc. in Methuen, MA.  

Phase

The Aging Brain ANSWERS Program

The majority of people with Alzheimer's (AD) and Traumatic brain Injury (TBI) are cared for in primary care settings and receive significant amounts of care and assistance in activities of daily living from family members or friends. The ABC ANSWERS intervention will incorporate and integrate the common features of an ...

Phase N/A

Technology Enabled Collaborative Care for Youth

The overall objective is to develop scalable interventions to address the physical health needs of patients affected by first episode psychosis (FEP). The objective of this project is to conduct a feasibility study of a high intensity Technology-Enabled Collaborative Care (TECC) model compared to lower intensity self-help modules and email ...

Phase N/A

Brain Energy for Amyloid Transformation in Alzheimer's Disease Study

This study will examine the effects of a 4-month Modified Mediterranean-Ketogenic Diet compared with an American Heart Association Diet (AHAD - a regimen that has been shown to reduce the risk for cardiovascular disease). We will investigate diet effects on AD biomarkers, on cognition, and on neuroimaging measures of blood ...

Phase N/A

Can Imagination Change Upsetting Memories of Trauma?

Research suggests that imagination is a powerful tool to change images inside our heads (e.g. memories) and make them less upsetting. It is thought that this occurs through changing the meaning attached to the memory (e.g. I am weak), therefore making it less upsetting to remember. Research has also linked ...

Phase

Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study

Depression is a common issue but there is no marker of response to an antidepressant treatment.The measurement of variation of the cortical excitability in responders to a selective serotonin reuptake inhibitor (SSRI) (compared to no-responders) had never been done before. In the study of Robol et al. (2004) concerning the ...

Phase N/A

Study of BHV-4157 in Alzheimer's Disease

Preclinical models suggest that riluzole, the active metabolite of BHV-4157, may protect from AD-related pathology and cognitive dysfunction. Titrated dose of BHV-4157 to 280 mg, or placebo, taken orally once daily. Duration of treatment is 48 weeks. There is also a screening period of up to 42 days; and a ...

Phase